Journal Publications

No. Author Title Journal Name Year/Month
1357 Park SE, Jeon Y, Kang S, Gedefaw A, Hailu D, Yeshitela B, Edosa M, Getaneh MW, Teferi M Infectious Disease Control and Management in Ethiopia: A Case Study of Cholera. Front Public Health 06/2022
1356 Liu Y, Pearson CAB, Sandmann FG, Barnard RC, Kim JH, Flasche S, Jit M, Abbas K Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis. Lancet Reg Health Eur 06/2022
1355 Jiamsiri S, Rhee C, Ahn HS, Poudyal N, Seo HW, Klinsupa W, Nilyanimit P, Premsri N, Namwat C, Vonpunsawad S, Chon Y, Park S, Kim DR, Unger ER, Markowitz L, Poovorawan Y, Rerks-Ngarm S, Excler JL, Lynch J A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand. PLoS One 05/2022
1354 Kim JH Managing Safe, Equitable, and Effective COVID-19 Vaccination. Development Asia 03/2022
1353 Lewitus E, Sanders-Buell E, Bose M, O'Sullivan AM, Poltavee K, Li Y, Bai H, Mdluli T, Donofrio G, Slike B, Zhao H, Wong K, Chen L, Miller S, Lee J, Ahani B, Lepore S, Muhammad S, Grande R, Tran U, Dussupt V, Mendez-Rivera L, Nitayaphan S, Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, O'Connell RJ, Janes H, Gilbert PB, Gramzinski R, Vasan S, Robb ML, Michael NL, Krebs SJ, Herbeck JT, Edlefsen PT, Mullins JI, Kim JH, Tovanabutra S, Rolland M RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection. Virus Evol 03/2022
1352 Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members Operation Warp Speed: implications for global vaccine security. Lancet Glob Health 03/2022
1351 Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics. Lancet 03/2022
1350 Panzner U, Excler JL, Kim JH, Marks F, Carter D, Siddiqui AA Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis. Front Trop Dis 03/2022
1349 Kim JH, McCann C The emergence of a South-South and Triangular Cooperation approach to vaccine development. J Glob Health Sci 03/2022
1348 Park SM, Gu MJ, Ju YJ, Cheon IS, Hwang KJ, Gill B, Shim BS, Jeong HJ, Son YM, Choi S, Jeung W, Han SH, Chu H, Yun CH Intranasal Vaccination with Outer-Membrane Protein of Orientia tsutsugamushi induces Protective Immunity Against Scrub Typhus. Immune Netw 03/2022
1347 Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. Lancet Infect Dis 03/2022
1346 Alexander N, Carabali M, Lim JK Estimating force of infection from serologic surveys with imperfect tests. PLoS One 03/2022
1345 Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries. BMC Med 03/2022
1344 Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Sci Rep 03/2022
1343 Mogasale V, Ngogoyo SM, Mogasale VV Model-based estimation of the economic burden of cholera in Africa. BMJ Open 03/2022
No.1357 Author Park SE, Jeon Y, Kang S, Gedefaw A, Hailu D, Yeshitela B, Edosa M, Getaneh MW, Teferi M
Title Infectious Disease Control and Management in Ethiopia: A Case Study of Cholera.
Journal Name Front Public Health
Month / Year 06/2022
No.1356 Author Liu Y, Pearson CAB, Sandmann FG, Barnard RC, Kim JH, Flasche S, Jit M, Abbas K
Title Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis.
Journal Name Lancet Reg Health Eur
Month / Year 06/2022
No.1355 Author Jiamsiri S, Rhee C, Ahn HS, Poudyal N, Seo HW, Klinsupa W, Nilyanimit P, Premsri N, Namwat C, Vonpunsawad S, Chon Y, Park S, Kim DR, Unger ER, Markowitz L, Poovorawan Y, Rerks-Ngarm S, Excler JL, Lynch J
Title A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand.
Journal Name PLoS One
Month / Year 05/2022
No.1354 Author Kim JH
Title Managing Safe, Equitable, and Effective COVID-19 Vaccination.
Journal Name Development Asia
Month / Year 03/2022
No.1353 Author Lewitus E, Sanders-Buell E, Bose M, O'Sullivan AM, Poltavee K, Li Y, Bai H, Mdluli T, Donofrio G, Slike B, Zhao H, Wong K, Chen L, Miller S, Lee J, Ahani B, Lepore S, Muhammad S, Grande R, Tran U, Dussupt V, Mendez-Rivera L, Nitayaphan S, Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, O'Connell RJ, Janes H, Gilbert PB, Gramzinski R, Vasan S, Robb ML, Michael NL, Krebs SJ, Herbeck JT, Edlefsen PT, Mullins JI, Kim JH, Tovanabutra S, Rolland M
Title RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection.
Journal Name Virus Evol
Month / Year 03/2022
No.1352 Author Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members
Title Operation Warp Speed: implications for global vaccine security.
Journal Name Lancet Glob Health
Month / Year 03/2022
No.1351 Author Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members
Title Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
Journal Name Lancet
Month / Year 03/2022
No.1350 Author Panzner U, Excler JL, Kim JH, Marks F, Carter D, Siddiqui AA
Title Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis.
Journal Name Front Trop Dis
Month / Year 03/2022
No.1349 Author Kim JH, McCann C
Title The emergence of a South-South and Triangular Cooperation approach to vaccine development.
Journal Name J Glob Health Sci
Month / Year 03/2022
No.1348 Author Park SM, Gu MJ, Ju YJ, Cheon IS, Hwang KJ, Gill B, Shim BS, Jeong HJ, Son YM, Choi S, Jeung W, Han SH, Chu H, Yun CH
Title Intranasal Vaccination with Outer-Membrane Protein of Orientia tsutsugamushi induces Protective Immunity Against Scrub Typhus.
Journal Name Immune Netw
Month / Year 03/2022
No.1347 Author Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD
Title Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
Journal Name Lancet Infect Dis
Month / Year 03/2022
No.1346 Author Alexander N, Carabali M, Lim JK
Title Estimating force of infection from serologic surveys with imperfect tests.
Journal Name PLoS One
Month / Year 03/2022
No.1345 Author Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M
Title Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
Journal Name BMC Med
Month / Year 03/2022
No.1344 Author Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V
Title A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India.
Journal Name Sci Rep
Month / Year 03/2022
No.1343 Author Mogasale V, Ngogoyo SM, Mogasale VV
Title Model-based estimation of the economic burden of cholera in Africa.
Journal Name BMJ Open
Month / Year 03/2022